Assessment of Synergistic Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Sarcoma.

Molecular Diagnosis & Therapy
Aikaterini MastorakiEmmanouil Pikoulis

Abstract

Sarcomas are a rare group of neoplasms with a mesenchymal origin that are mainly characterized by the abnormal growth of connective tissue cells. The standard treatment for local control of sarcomas includes surgery and radiation, while for adjuvant and palliative therapy, chemotherapy has been strongly recommended. Despite the availability of multimodal therapies, the survival rate for patients with sarcoma is still not satisfactory. In recent decades, there has been a considerable effort to overcome chemotherapy resistance in sarcoma cells. This has led to the investigation of more cellular compounds implicated in gene expression and transcription processes. Furthermore, it has been discovered that histone acetylation/deacetylation equilibrium is affected in carcinogenesis, leading to a modified chromatin structure and therefore changes in gene expression. In addition, histone deacetylase inhibition is found to play a key role in limiting the tumor burden in sarcomas, as histone deacetylase inhibitors act on well-described oncogenic signaling pathways. Histone deacetylase inhibitors disrupt the increased cell motility and invasiveness of sarcoma cells, undermining their metastatic potential. Moreover, their activity on evokin...Continue Reading

References

Jan 19, 2000·Nature·B D Strahl, C D Allis
Apr 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Qin C RyanEdward A Sausville
Feb 27, 2007·Cell·Tony Kouzarides
Mar 24, 2007·Nature Reviews. Molecular Cell Biology·Kenneth K Lee, Jerry L Workman
Oct 17, 2007·Molecular and Cellular Biology·Ya-sheng GaoTso-Pang Yao
Nov 3, 2007·Mayo Clinic Proceedings·Keith M Skubitz, David R D'Adamo
Feb 16, 2010·The Lancet Oncology·Naomi J Balamuth, Richard B Womer
May 13, 2010·Investigational New Drugs·Mark Andrew DicksonGary K Schwartz
Oct 20, 2010·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Erik R SampsonRandy N Rosier
Oct 6, 2012·Clinical Sarcoma Research·Zachary BurninghamJoshua D Schiffman
Feb 23, 2013·RNA·Neil Brockdorff
Oct 1, 2011·Therapeutic Advances in Hematology·Batia Avni, Maya Koren-Michowitz
Aug 8, 2013·Obstetrics and Gynecology·J Alejandro Rauh-Hain, Marcela G del Carmen
Oct 8, 2013·Hematology/oncology Clinics of North America·César Serrano, Suzanne George
Oct 8, 2013·Hematology/oncology Clinics of North America·Jolieke G van OosterwijkJudith V M G Bovée
Oct 12, 2013·Investigational New Drugs·William R SchelmanHoward H Bailey
Mar 26, 2014·Expert Review of Anticancer Therapy·Emanuela PalmeriniStefano Ferrari
Jun 6, 2014·Cellular and Molecular Life Sciences : CMLS·Jing Zhang, Qing Zhong
Aug 15, 2014·Oncotarget·Michiel KroesenGosse J Adema
Oct 10, 2014·Advances in Anatomic Pathology·Christopher M J Conklin, Teri A Longacre
Oct 23, 2014·Journal of Surgical Oncology·David M Thomas, Mandy L Ballinger
Jan 30, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Q S-C ChuE A Eisenhauer
Aug 26, 2015·Drug Development Research·Saira R AliMichael Z Michael
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nathalie GasparOdile Oberlin
Feb 4, 2016·Nature Communications·Michael S NakazawaM Celeste Simon
Feb 24, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S ThomasP N Munster
Jul 2, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Thomas SchmittGerlinde Egerer
Aug 21, 2016·The Surgical Clinics of North America·Christina J GutowskiJohn A Abraham
Sep 7, 2016·Progress in Tumor Research·Andrea FerrariStefan Bielack
Nov 28, 2016·Neoplasia : an International Journal for Oncology Research·Sally E HendersonPo-Hsien Huang
Dec 14, 2016·Proceedings of the National Academy of Sciences of the United States of America·Michael P PhelpsEleanor Y Chen
Jan 23, 2017·BMC Cancer·Sridhar MurahariWilliam C Kisseberth
Jan 27, 2017·Gynecologic and Obstetric Investigation·Min-Hyun BaekJoo-Hyun Nam
Feb 22, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rahul AggarwalPamela N Munster
Mar 28, 2017·Clinical Lymphoma, Myeloma & Leukemia·L Max AlmondAnant Desai
Jun 15, 2017·Cancer Chemotherapy and Pharmacology·Jürgen BurhenneGerlinde Egerer
Jul 4, 2017·International Journal of Molecular Sciences·Tomas EckschlagerJan Hrabeta

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation
surgical resection
xenograft
hysterectomy
histone acetylation

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis